KBC Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

KBC Group’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-56,500	Closed	-$6K	–	1458
2018 Q4	$6K	Hold	56,500	–	–	﹤0.01%	1301
2018 Q3	$96K	Hold	56,500	–	–	﹤0.01%	1298
2018 Q2	$98K	Hold	56,500	–	–	﹤0.01%	1193
2018 Q1	$103K	Buy	56,500 +32,700	+137%	+$69.1K	﹤0.01%	1181
2017 Q4	$53K	Buy	+23,800	New	+$59.2K	﹤0.01%	1204

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

KBC Group's SGYP Position: Q1 2019 in Review

KBC Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 56,500 shares — an estimated $6K sold.

KBC Group first reported a position in SGYP in Q4 2017 and held it in 5 quarters. The position peaked at $103K in Q1 2018. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

KBC Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
KBC Group sold 56,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $6K.
KBC Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2017 and held it in 5 quarters.
KBC Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $103K in Q1 2018.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on KBC Group's 13F filing for Q1 2019, filed 10 May 2019.